Cord blood mononuclear cell transformation assay for screening for the presence of Epstein-Barr virus

K. G. Lucas, R. Burton, D. K. Heilman, Karen Pollok, D. Emanuel

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

EBV-induced lymphoproliferative disease (EBV-LPD) is a serious and potentially fatal complication following stem cell transplantation. Strategies have been developed for the cultivation of donor-derived, EBV- specific cytotoxic T lymphocytes (CTL) for stem cell transplant (SCT) patients affected with these disorders, using donor-derived, EBV-transformed B lymphoblastoid cell lines (BLCL) as stimulators. Although cultivation of EBV-transformed BLCL is possible without using an exogenous source of EBV, transformation of autologous B cells with endogenous virus may be slow and inconsistent. Therefore, if exogenous strains of EBV are used to generate BLCL, it may be beneficial to patients to ensure that these cell lines are not producing virus that potentially could be conveyed at the time of CTL infusion. A reliable method of screening for EBV using a cord blood transformation assay has been developed and is described.

Original languageEnglish (US)
Pages (from-to)587-590
Number of pages4
JournalJournal of Hematotherapy
Volume6
Issue number6
StatePublished - 1997

Fingerprint

Human Herpesvirus 4
Fetal Blood
Blood Cells
Cell Line
Cytotoxic T-Lymphocytes
Tissue Donors
Viruses
Stem Cell Transplantation
B-Lymphocytes
Stem Cells
Transplants

ASJC Scopus subject areas

  • Hematology
  • Immunology

Cite this

Cord blood mononuclear cell transformation assay for screening for the presence of Epstein-Barr virus. / Lucas, K. G.; Burton, R.; Heilman, D. K.; Pollok, Karen; Emanuel, D.

In: Journal of Hematotherapy, Vol. 6, No. 6, 1997, p. 587-590.

Research output: Contribution to journalArticle

Lucas, K. G. ; Burton, R. ; Heilman, D. K. ; Pollok, Karen ; Emanuel, D. / Cord blood mononuclear cell transformation assay for screening for the presence of Epstein-Barr virus. In: Journal of Hematotherapy. 1997 ; Vol. 6, No. 6. pp. 587-590.
@article{2630f2a59495431785888fabc1882022,
title = "Cord blood mononuclear cell transformation assay for screening for the presence of Epstein-Barr virus",
abstract = "EBV-induced lymphoproliferative disease (EBV-LPD) is a serious and potentially fatal complication following stem cell transplantation. Strategies have been developed for the cultivation of donor-derived, EBV- specific cytotoxic T lymphocytes (CTL) for stem cell transplant (SCT) patients affected with these disorders, using donor-derived, EBV-transformed B lymphoblastoid cell lines (BLCL) as stimulators. Although cultivation of EBV-transformed BLCL is possible without using an exogenous source of EBV, transformation of autologous B cells with endogenous virus may be slow and inconsistent. Therefore, if exogenous strains of EBV are used to generate BLCL, it may be beneficial to patients to ensure that these cell lines are not producing virus that potentially could be conveyed at the time of CTL infusion. A reliable method of screening for EBV using a cord blood transformation assay has been developed and is described.",
author = "Lucas, {K. G.} and R. Burton and Heilman, {D. K.} and Karen Pollok and D. Emanuel",
year = "1997",
language = "English (US)",
volume = "6",
pages = "587--590",
journal = "Stem Cells and Development",
issn = "1547-3287",
publisher = "Mary Ann Liebert Inc.",
number = "6",

}

TY - JOUR

T1 - Cord blood mononuclear cell transformation assay for screening for the presence of Epstein-Barr virus

AU - Lucas, K. G.

AU - Burton, R.

AU - Heilman, D. K.

AU - Pollok, Karen

AU - Emanuel, D.

PY - 1997

Y1 - 1997

N2 - EBV-induced lymphoproliferative disease (EBV-LPD) is a serious and potentially fatal complication following stem cell transplantation. Strategies have been developed for the cultivation of donor-derived, EBV- specific cytotoxic T lymphocytes (CTL) for stem cell transplant (SCT) patients affected with these disorders, using donor-derived, EBV-transformed B lymphoblastoid cell lines (BLCL) as stimulators. Although cultivation of EBV-transformed BLCL is possible without using an exogenous source of EBV, transformation of autologous B cells with endogenous virus may be slow and inconsistent. Therefore, if exogenous strains of EBV are used to generate BLCL, it may be beneficial to patients to ensure that these cell lines are not producing virus that potentially could be conveyed at the time of CTL infusion. A reliable method of screening for EBV using a cord blood transformation assay has been developed and is described.

AB - EBV-induced lymphoproliferative disease (EBV-LPD) is a serious and potentially fatal complication following stem cell transplantation. Strategies have been developed for the cultivation of donor-derived, EBV- specific cytotoxic T lymphocytes (CTL) for stem cell transplant (SCT) patients affected with these disorders, using donor-derived, EBV-transformed B lymphoblastoid cell lines (BLCL) as stimulators. Although cultivation of EBV-transformed BLCL is possible without using an exogenous source of EBV, transformation of autologous B cells with endogenous virus may be slow and inconsistent. Therefore, if exogenous strains of EBV are used to generate BLCL, it may be beneficial to patients to ensure that these cell lines are not producing virus that potentially could be conveyed at the time of CTL infusion. A reliable method of screening for EBV using a cord blood transformation assay has been developed and is described.

UR - http://www.scopus.com/inward/record.url?scp=0031407364&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031407364&partnerID=8YFLogxK

M3 - Article

C2 - 9483194

AN - SCOPUS:0031407364

VL - 6

SP - 587

EP - 590

JO - Stem Cells and Development

JF - Stem Cells and Development

SN - 1547-3287

IS - 6

ER -